|
|
|
|
|
 |
|
Strategy - Sectors approach |
|
 |
|
|
The Solvay group operates in three Sectors of activity: Pharmaceuticals, Chemicals and Plastics.
 |
Pharmaceuticals Sector
En route for tomorrow’s Solvay Pharmaceuticals
Sales 2007: EUR 2.6 billion
REBIT* 2007: EUR 457 million
9 178 employees
Therapeutic fields
Integrated franchises (R&D and commercial)
- Cardiometabolics (dyslipidemia, obesity, type 2 diabetes, congestive heart failure, renal insufficiency, atrial fibrillation)
- Neuroscience (schizophrenia, Parkinson’s disease, traumatic brain injury, cognition)
- Niches in flu vaccines and pancreatic enzymes
Commercial franchises
- Gastroenterology
- Women’s and men’s health
Strategic priorities (2010)
- Concentration on therapeutic fields
- Improving profitability:
Operating margin**: 20%
Efficiency improvements: EUR 300 million of annual savings
- Sales: EUR 3.2 billion
- Increasing the R&D/sales ratio
|
 |
Chemicals Sector
On the path of growth
Sales 2007: EUR 3.0 billion
REBIT* 2007: EUR 345 million
8 395 employees
4 clusters
Minerals
- Soda ash and derivatives (bicarbonate)
- Advanced Functional Minerals (precipitated calcium carbonate)
Electrochemistry, Fluorinated products
- Electrochemicals and derivatives (caustic soda, epichlorohydrin)
- Fluorinated products
Oxygen
- Hydrogen peroxide
- Detergents (persalts)
Organic (Molecular Solutions)
Strategic priorities
- Intensifying our geographic expansion
- Pursuing technological innovation
- Growth in specialties (mainly bicarbonate and fluorinated and organic specialties)
- Competitiveness
|
 |
Plastics Sector
Enriching our product portfolio and fully exploiting our strengths
Sales 2007: EUR 4.0 billion
REBIT* 2007: EUR 441 million
8 977 employees
2 clusters
Specialties
- Specialty Polymers (high and ultra-high performance polymers like fluorinated polymers, elastomers and fluids, barrier materials, polyarylamides, polysulfones, high performance polyamides, liquid crystal polymers)
- Inergy Automotive Systems (50/50 joint venture with Plastic Omnium)
Vinyls
- Vinyls (integrated electrolysis chain, VCM (monomer), PVC (polymer) and PVC compounds)
- Pipelife (50/50 joint venture with Wienerberger)
Strategic priorities
- Globalization
- R&D and technological innovation
- Product leadership
- Competitiveness
* REBIT= "Recurring Earnings Before Interests and Taxes" = operating results
** REBIT/sales
|
|
|
|
|
|
|
|
|
